Literature DB >> 18239450

Unbiased vs. biased approaches to the identification of cancer signatures: the case of lung cancer.

Fabrizio Bianchi1, Francesco Nicassio, Pier Paolo Di Fiore.   

Abstract

Expression profiling analysis of human cancers is a promising approach to obtain precise molecular classification of cancers, to develop stratification tools for therapeutic regimens, and to predict the biological behavior of neoplasia. Direct profiling of human cancers (herein defined as "the unbiased approach") presents, however, intrinsic problems connected with the high genetic noise embedded in the system. This, in turn, leads to fitting of the noise in the data (the so-called "overtraining") with consequent instability of the identified signatures, when applied on different cohorts of patients. To circumvent these problems, "biased approaches" - which exploit the molecular knowledge of cancer obtained in model systems - are being developed. Biased approaches, however, are not problem-free, in that they provide information limited to single oncogenic events, thereby failing, at least in principle, to capture the complex repertoire of alterations of human cancers. In this review, we compare the two approaches and provide a test case, from our studies, of how "integrated" strategies, which combine biased and unbiased approaches, might lead to the identification of stable and reliable predictive signatures in cancer.

Entities:  

Mesh:

Year:  2008        PMID: 18239450     DOI: 10.4161/cc.7.6.5591

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  6 in total

Review 1.  A role for cancer stem cells in drug resistance and metastasis in non-small-cell lung cancer.

Authors:  Rosario Perona; Blanca D López-Ayllón; Javier de Castro Carpeño; Cristóbal Belda-Iniesta
Journal:  Clin Transl Oncol       Date:  2011-05       Impact factor: 3.405

2.  Multigene Profiling of CTCs in mCRPC Identifies a Clinically Relevant Prognostic Signature.

Authors:  Udit Singhal; Yugang Wang; James Henderson; Yashar S Niknafs; Yuanyuan Qiao; Amy Gursky; Alexander Zaslavsky; Jae-Seung Chung; David C Smith; R Jeffrey Karnes; S Laura Chang; Felix Y Feng; Ganesh S Palapattu; Russell S Taichman; Arul M Chinnaiyan; Scott A Tomlins; Todd M Morgan
Journal:  Mol Cancer Res       Date:  2018-02-16       Impact factor: 5.852

3.  Determination of SGK1 mRNA in non-small cell lung cancer samples underlines high expression in squamous cell carcinomas.

Authors:  Claudia Abbruzzese; Stefano Mattarocci; Laura Pizzuti; Anna M Mileo; Paolo Visca; Barbara Antoniani; Gabriele Alessandrini; Francesco Facciolo; Rosario Amato; Lucia D'Antona; Massimo Rinaldi; Armando Felsani; Nicola Perrotti; Marco G Paggi
Journal:  J Exp Clin Cancer Res       Date:  2012-01-12

4.  Tumor analysis: freeze-thawing cycle of triple-negative breast cancer cells alters tumor CD24/CD44 profiles and the percentage of tumor-infiltrating immune cells.

Authors:  Matthieu Le Gallo; Thibault de la Motte Rouge; Amanda Poissonnier; Vincent Lavoué; Patrick Tas; Jean Leveque; Florence Godey; Patrick Legembre
Journal:  BMC Res Notes       Date:  2018-06-20

Review 5.  Serum and Glucocorticoid-Inducible Kinase 1 (SGK1) in NSCLC Therapy.

Authors:  Ilaria Guerriero; Gianni Monaco; Vincenzo Coppola; Arturo Orlacchio
Journal:  Pharmaceuticals (Basel)       Date:  2020-11-22

6.  Prognostic value of molecular events from negative surgical margin of non-small-cell lung cancer.

Authors:  Bangrong Cao; Lin Feng; Dan Lu; Yan Liu; Yu Liu; Suping Guo; Naijun Han; Xiangyang Liu; Yousheng Mao; Jie He; Shujun Cheng; Yanning Gao; Kaitai Zhang
Journal:  Oncotarget       Date:  2016-07-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.